Halozyme Therapeutics, Inc.HALONASDAQ
Loading
Gross Profit Growth Under PressureDecelerating
Percentile Rank50
3Y CAGR-14.5%
5Y CAGR-10.9%
Year-over-Year Change
Year-over-year gross profit growth rate
3Y CAGR
-14.5%/yr
Annual compound
5Y CAGR
-10.9%/yr
Recent deceleration
Percentile
P50
Within normal range
vs 5Y Ago
0.6x
Contraction
Streak
1 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2025 | 27.49% |
| 2024 | 34.39% |
| 2023 | 22.29% |
| 2022 | 43.91% |
| 2021 | 61.40% |
| 2020 | 49.04% |
| 2019 | 6.15% |
| 2018 | -50.35% |
| 2017 | 151.54% |
| 2016 | 7.25% |